NewGenIvf Sets 1-for-3 Reverse Split for September 1
NIVF sits 16% above its 52-week low of $0.451 on light trading volume (0.3× avg).
Summary
NewGenIvf Group Ltd announced a 1-for-3 reverse stock split effective September 1, 2026, reducing outstanding shares from 6.31 million to approximately 2.10 million.
Key Events · Corporate Governance and Compliance · NIVF
-
Reverse Stock Split Approved
On July 31, 2026, the board approved a 1-for-3 reverse stock split, reducing outstanding Class A shares from 6,307,870 to approximately 2,102,623.
-
Effective Date and Trading
The split takes effect at 12:01 a.m. ET on September 1, 2026; shares will trade on a split-adjusted basis under new CUSIP G0544E154.
-
No Shareholder Vote Required
Under the BVI Business Companies Act and the company's M&A, the board is authorized to effect the reverse split without shareholder approval.
-
Adjustment of Convertible Securities
All outstanding options, warrants, and convertible securities will be adjusted by dividing the number of underlying shares by three, subject to rounding.
Analysis · NIVF · Industrial Applications And Services
A 1-for-3 reverse stock split was approved by the board on July 31, 2026, cutting outstanding Class A shares from 6.31 million to roughly 2.10 million. The split becomes effective September 1, 2026, and no shareholder vote is required under BVI law. The move appears designed to lift the share price, currently at $0.5244, likely to preserve Nasdaq listing compliance. All outstanding options, warrants, and convertible securities will be adjusted proportionally.
At the time of this filing, NIVF was trading at $0.52 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.3M. The 52-week trading range was $0.45 to $513.00. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.